28May 2024
Unlocking the Cardiovascular Benefits of SGLT-2 Inhibitors Beyond Diabetes Treatment

Unlocking the Cardiovascular Benefits of SGLT-2 Inhibitors Beyond Diabetes Treatment

SGLT-2 inhibitors, proven through trials and real-world data, offer significant cardiovascular benefits beyond antidiabetic effects, aiding in preventing CVD in DM patients. Their efficacy extends to nondiabetic CVD and renal disease. Despite ongoing research into their molecular mechanisms, their role in CVD prevention is crucial for diverse medical specialists. This review presents evidence supporting their rational clinical use.

  • #cardiology

Like

Save

Share